gebhart/patrepeval huggingface dataset:
Cyclosporin A inhibits dendritic cell maturation promoted by TNF-alpha or LPS but not by double-stranded RNA or CD40L. (2002)

Here, we investigated the influence of cyclosporin A (CsA) on dendritic cell (DC) generation. With this aim, human DC were propagated from monocytes in serum-free medium with granulocyte macrophage-colony stimulating factor and interleukin-4. DC were then exposed to tumor necrosis factor alpha (TNF-alpha) for maturation. Our results show that CsA does not impair commitment of monocytes into DC, as assessed by loss of CD14 and increase of CD40 and CD1a. However, TNF-alpha-induced DC maturation was affected, as CsA-treated DC expressed lower levels of human leukocyte antigen and costimulatory molecules but sustained levels of CD1a, and less DC expressed DC-lysosomal-associated-membrane-protein (LAMP) and CD83. Accordingly, CsA inhibited the allostimulatory and accessory cell functions of DC. Surprisingly, when other maturation stimuli were used, we observed that CsA significantly inhibited maturation induced by lipopolysaccharides but not by polyribocytidylic acid or CD40 ligand, as assessed by DC phenotype and functions. Therefore, our results indicate that CsA may differentially affect DC maturation.
A Phase II Clinical Trial of Flutamide in the Treatment of Advanced Breast Cancer (1988)

An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.
PRIMER ON THE RHEUMATIC DISEASES (1949)

<h3>RHEUMATOID ARTHRITIS</h3><h3>ETIOLOGY</h3> Rheumatoid arthritis is a disease of unknown causation. Many theories of causation have been proposed but none has withstood critical evaluation. Some known facts are that it has a slight tendency to be familial; the sex incidence in peripheral rheumatoid arthritis is 3 women to 1 man, and 80 per cent of the cases occur between the ages of 25 to 50, with the peak at 35 to 40. According to a number of current theories, rheumatoid arthritis is variously claimed to be (1) an infectious disease, (2) a metabolic disease, (3) a disease with an endocrinologic basis, (4) a disease of the peripheral circulatory apparatus, (5) a disease of the nervous system, (6) a psychogenic disease and (7) a disease of hypersensitivity. Such a list as this indicates how little actually is known about the cause of rheumatoid arthritis. <h3>PATHOLOGY</h3> Rheumatoid arthritis is invariably described as
Characteristics of inhibitors in mild/moderate haemophilia A (2006)

Patients with mild or moderate haemophilia A usually have a mild bleeding disorder requiring only occasional treatment with factor VIII (FVIII) concentrates. The frequency of inhibitor development in such patients has been the subject of several recent surveys, which significantly modified our appreciation of this complication. Studies of the anti-FVIII antibodies provided an explanation for the different bleeding phenotypes observed in mild/moderate haemophilia A patients with inhibitors. Antibodies distinguishing between the patient's mutant FVIII and the normal wild-type FVIII were characterized, in addition to antibodies inhibiting completely or only partially FVIII activity. T lymphocytes recognizing FVIII and likely involved in the development of the immune response to FVIII were successfully identified. The FVIII peptides recognized by those FVIII-specific cells bind to many major histocompatibility complex (MHC) class II molecules, which may provide an explanation for the lack of strong association between MHC haplotypes and inhibitor development. Although these studies have advanced our understanding of the conditions leading to inhibitor development, further work is required to determine whether the mode of FVIII administration significantly influences inhibitor development. Further studies of the genetic factors are also required to fully understand the mechanisms leading to inhibitor development in patients with mild/moderate haemophilia A.
Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma (2009)

Stimulation of CD40 or Toll-Like Receptors (TLR) has potential for tumor immunotherapy. Combinations of CD40 and TLR stimulation can be synergistic, resulting in even stronger dendritic cell (DC) and CD8+ T cell responses. To evaluate such combinations, established B16F10 melanoma tumors were injected every other day X 5 with plasmid DNA encoding a multimeric, soluble form of CD40L (pSP-D-CD40L) either alone or combined with an agonist for TLR1/2 (Pam(3)CSK(4) ), TLR2/6 (FSL-1 and MALP2), TLR3 (polyinosinic-polycytidylic acid, poly(I:C)), TLR4 ( monophosphoryl lipid A, MPL), TLR7 (imiquimod), or TLR9 (Class B CpG phosphorothioate oligodeoxynucleotide, CpG). When used by itself, pSP-D-CD40L slowed tumor growth and prolonged survival, but did not lead to cure. Of the TLR agonists, CpG and poly(I:C) also slowed tumor growth, and the combination of these two TLR agonists was more effective than either agent alone. The triple combination of intratumoral pSP-D-CD40L + CpG + poly(I:C) markedly slowed tumor growth and prolonged survival. This treatment was associated with a reduction in intratumoral CD11c+ dendritic cells and an influx of CD8+ T cells. Since intratumoral injection of plasmid DNA does not lead to efficient transgene expression, pSP-D-CD40L was also tested with cationic polymers that form DNA-containing nanoparticles which lead to enhanced intratumoral gene expression. Intratumoral injections of pSP-D-CD40L-containing nanoparticles formed from polyethylenimine (PEI) or C32 (a novel biodegradable poly(B-amino esters) polymer) in combination with CpG + poly(I:C) had dramatic antitumor effects and frequently cured mice of B16F10 tumors. These data confirm and extend previous reports that CD40 and TLR agonists are synergistic and demonstrate that this combination of immunostimulants can significantly suppress tumor growth in mice. In addition, the enhanced effectiveness of nanoparticle formulations of DNA encoding immunostimulatory molecules such as multimeric, soluble CD40L supports the further study of this technology for tumor immunotherapy.
Chemotherapy-Induced Immunomodulation in Non-Small-Cell Lung Cancer: A Rationale for Combination Chemoimmunotherapy (2017)

Spurred by the survival benefits seen with the use of checkpoint blockade in non-small-cell lung cancer (NSCLC), there has been a growing interest in the potential applications of immunotherapy. Despite this, the objective response rate for single-agent immunotherapy remains ≤20% in patients with advanced NSCLC. A combinatorial approach that utilizes both chemotherapy and immunotherapy is a potential strategy to increase antitumor efficacy. Accumulating evidence has shown that the immunomodulatory effects of chemotherapeutic agents can be exploited in a combinational approach. Herein, we review the influence of specific chemotherapeutic agents on the tumor immune microenvironment in preclinical and clinical studies, and establish the rationale for combination chemoimmunotherapy for the treatment of NSCLC.
Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. (1992)

In this study, mediators of inflammation were characterized in colonic and terminal ileum mucosa from subjects with ulcerative colitis. We considered the role of two different chemotactic factors (interleukin-8 and leukotriene B4) and of myeloperoxidase in the pathology of inflammatory bowel disease. Serial biopsy specimens were taken at different sites, washed in 0.02 M phosphate/saline buffer, homogenized, and then sonically disrupted. In both the proximal and distal regions of the colonic mucosa of ulcerative colitis patients, there was a more than 10-fold increase in interleukin-8 levels over that in control subjects (> 300 pg/mg protein vs. 30 pg/mg protein in controls, p < or = 0.01). However, terminal ileum levels of interleukin-8 were the same in ulcerative colitis and control groups (150 pg/mg protein). There was also a 3- to 5-fold increase in leukotriene B4 levels and a several-fold increase in myeloperoxidase levels throughout the colonic mucosa in patients with ulcerative colitis. This study demonstrates that 1) interleukin-8 may have an immunoregulatory role in the pathogenesis of inflammatory bowel disease, and 2) interleukin-8, myeloperoxidase, and leukotriene B4 may be useful markers for the biochemical identification of inflammatory bowel disease.
Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target (2015)

SCD1 is a novel oncogenic factor specifically required for tumor cell viability in ATC. Furthermore, the expression of SCD1 appears to be correlated with thyroid tumor aggressiveness and may serve as a prognostic biomarker. These findings substantiate SCD1 as a novel tumor-specific target for therapy in patients with ATC and should be further investigated in a clinical setting.
Reductive Methylation of Steroid Ketones (1952)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTReductive Methylation of Steroid KetonesJohn C. Babcock and Louis F. FieserCite this: J. Am. Chem. Soc. 1952, 74, 21, 5472–5474Publication Date (Print):November 1, 1952Publication History Published online1 May 2002Published inissue 1 November 1952https://doi.org/10.1021/ja01141a073RIGHTS & PERMISSIONSArticle Views131Altmetric-Citations14LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (389 KB) Get e-Alertsclose Get e-Alerts
Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia (1998)

The efficacy of allografting in acute lymphoblastic leukemia (ALL) is heavily influenced by remission status at the time of transplant. Using polymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis, we have investigated retrospectively the impact of submicroscopic leukemia on outcome in 64 patients receiving allogeneic bone marrow transplantation (BMT) for childhood ALL. Remission BM specimens were taken 6 to 81 days (median, 23) before transplant. All patients received similar conditioning therapy; 50 received grafts from unrelated donors and 14 from related donors. Nineteen patients were transplanted in first complete remission (CR1) and 45 in second or subsequent CR. MRD was analyzed by PCR of Ig or T-cell receptor delta or gamma rearrangements, electrophoresis, and allele-specific oligoprobing. Samples were rated high-level positive (clonal band evident after electrophoresis; sensitivity 10(-2) to 10(-3)), low-level positive (MRD detected only after oligoprobing; sensitivity 10(-3) to 10(-5)), or negative. Excluding 8 patients transplanted in CR2 for isolated extramedullary relapse (all MRD-), MRD was detected at high level in 12 patients, low level in 11, and was undetectable in 33. Two-year event-free survival for these groups was 0%, 36%, and 73%, respectively (P <.001). Follow-up in patients remaining in continuing remission is 20 to 96 months (median, 35). These results suggest that MRD analysis could be used routinely in this setting. This would allow identification of patients with resistant leukemia (who may benefit from innovative BMT protocols) and of those with more responsive disease (who may be candidates for randomized trials of BMT versus modern intensive relapse chemotherapy).
The Languages of the Pacific (1993)

The quantity of materials in languages of the Pacific is expected to increase in American and European libraries in the com- ing decades. This essay presents descriptions of the major language mourn of Melanesia, Micronesia, and Polynesia and a discussion of h ~ e s which the cataloger will encounter h dealing with these mate- rials, Also discussed are creole and vidnin languages of the Pacific. the body of literature in Pacific vemadars, &reatend languages, shared cataloging, meeting the special needs of library users, and dealing with Library of Congress classification and subject headings and with Dewey classification.
Virtual Fluoroscopy: Computer-Assisted Fluoroscopic Navigation (2001)

Virtual fluoroscopy offers several advantages over conventional fluoroscopy while providing acceptable targeting accuracy. It enables a single C-arm to provide real-time, multiplanar procedural guidance. It also dramatically reduces radiation exposure to the patient and surgical team by eliminating the need for repetitive fluoroscopic imaging for tool placement.
The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human Keratinocytes (1999)

The L1 major capsid protein of human papillomavirus (HPV) type 11, a 55-kDa polypeptide, forms particulate structures resembling native virus with an average particle diameter of 50-60 nm when expressed in the yeast Saccharomyces cerevisiae. We show in this report that these virus-like particles (VLPs) interact with heparin and with cell-surface glycosaminoglycans (GAGs) resembling heparin on keratinocytes and Chinese hamster ovary cells. The binding of VLPs to heparin is shown to exhibit an affinity comparable to that of other identified heparin-binding proteins. Immobilized heparin chromatography and surface plasmon resonance were used to show that this interaction can be specifically inhibited by free heparin and dextran sulfate and that the effectiveness of the inhibitor is related to its molecular weight and charge density. Sequence comparison of nine human L1 types revealed a conserved region of the carboxyl terminus containing clustered basic amino acids that bear resemblance to proposed heparin-binding motifs in unrelated proteins. Specific enzymatic cleavage of this region eliminated binding to both immobilized heparin and human keratinocyte (HaCaT) cells. Removal of heparan sulfate GAGs on keratinocytes by treatment with heparinase or heparitinase resulted in an 80-90% reduction of VLP binding, whereas treatment of cells with laminin, a substrate for alpha6 integrin receptors, provided minimal inhibition. Cells treated with chlorate or substituted beta-D-xylosides, resulting in undersulfation or secretion of GAG chains, also showed a reduced affinity for VLPs. Similarly, binding of VLPs to a Chinese hamster ovary cell mutant deficient in GAG synthesis was shown to be only 10% that observed for wild type cells. This report establishes for the first time that the carboxyl-terminal portion of HPV L1 interacts with heparin, and that this region appears to be crucial for interaction with the cell surface.
Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus (1982)

Electron microscopic studies of the dentate gyrus of the rat have revealed an apparent association between polyribosomes and dendritic spines. The present study was designed to elucidate the nature of this association. Our qualitative observations revealed that polyribosomes appeared primarily in two locations within the dendrite: (1) beneath the base of identified spines just subjacent to the intersection of the spine neck with the main dendritic shaft and (2) beneath mounds in the dendritic membrane which had the appearance of the base of a spine which extended out of the plane of section. To quantitatively define the nature of the apparent association, we attempted to determine (1) the proportion of spines with associated polyribosomes and (2) the proportion of the polyribosomes within dendrites which are associated with spine bases. Evaluation of profiles which were identifiable as spine neck-dendritic shaft intersections in a single section revealed that an average of 12.2% had associated polyribosomes. A serial section analysis revealed a somewhat higher incidence, however. Of a collection of 34 through-sectioned spines, 29% had polyribosomes which were revealed in one or more of the sections comprising the series. To evaluate what proportion of polyribosomes within the dendrite was associated with spines, we evaluated a series of photographs covering approximately 1250 micrometer2 of the dentate molecular layer from five animals, identifying all polyribosomes within dendrites and scoring their location as being (1) under spines, (2) under mounds, or (3) other. An average of 9.6% of the polyribosomes were found under processes identifiable as spine neck-dendritic shaft intersections, while 71.4% of the polyribosomes were found under mounds. Only 19% were not obviously associated with spines or mounds. Spine bases and mounds comprise only 3 of 35%, respectively, of the outline of dendritic profiles, however, indicating that the high incidence of polyribosomes under these elements cannot be accounted for by chance. To attempt to determine whether the mounds represent the base of dendritic spines, 68 mounds in 21 dentritic profiles were selected from the middle of the series of 20 serial sections. Ninetine of these mounds (28%) were continuous with an identified spine, and an additional 31% were continuous with thin processes of the size and appearance of spine necks. Thus, most of the mounds probably do represent the base of spines which extend out of the plane of a single section.
Asymmetric Synthesis and DNA Intercalation of (−)-6-[[(Aminoalkyl)oxy]methyl]-4-demethoxy-6,7- dideoxydaunomycinones1, (1996)

The BF(3).Et(2)O-promoted Diels-Alder addition of 1-acetylvinyl RADO(Et)-ate (RADO(Et)-ate = 3-ethyl-2-oxo-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-exo-carboxylate) to 1-(dimethoxymethyl)-2,3,5,6-tetramethylidene-7-oxabicyclo[2.2.1]heptane led to one major monoadduct that added to 1,2-didehydrobenzene and was converted into (-)-4-demethoxy-7-deoxydaunomycinone and (2R)-12-acetoxy-2-acetyl-5-(bromomethyl)-1,2,3,4-tetrahydronaphthacen-2-yl RADO(Et)-ate. The latter compound was used to construct (8R)-8-acetyl-6,8-dihydroxy-11-[[(3'-[(aminopropyl)oxy]-, -4'-[(aminobutyl)oxy], and -5'-[(aminopentyl)oxy]methyl]-7,8,9,10-tetrahydronaphthacene-5,12-dione hydrochloride (-)-8, (-)-9, (-)-10, respectively, as well as (8R)-8-acetyl-6,8-dihydroxy-11- [[[2'-[(3"-aminopropyl)amino]ethyl]oxy]- ((-)-11) and -[[3'-[(3"-aminopropyl)amino]propyl]oxy]methyl]-7,8,9, 10-tetrahydronaphthacene-5,12-dione hydrochloride ((-)-12). (8R)-8-Acetyl-6,8-dihydroxy-11-[[(alpha-L-daunosaminyl)oxy]methyl]-7,8,9,10-tetrahydronaphthacene-5,12-dione hydrochloride ((-)-13), a mimic of idarubicin, was also prepared. Absorbance and fluorescence titration experiments showed (-)-8, (-)-9, and (-)-10 to intercalate calf thymus DNA whereas (-)-11, (-)-12, and (-)-13 did not. The best intercalator was (-)-9 (K(b) = (1.1 +/- 0.1) x 10(5) M(-)(1)) with the [(4'-aminobutyl)oxy]methyl chain. Inhibition of topoisomerase II-induced DNA strand religation was observed for (-)-8 at a concentration of 50 &mgr;M.
Radioimmunoassay for Cyclic Nucleotides (1972)

Abstract The levels of cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) were measured in eight regions of mouse central nervous system (CNS), utilizing a recently developed radioimmunological assay. The effect of postnatal development and of ischemia on regional CNS cAMP and cGMP levels were studied also. Levels of cAMP were found to vary from 0.6 µmole per kg, wet weight, in spinal cord to 2.3 µmoles per kg, wet weight, in striatum. cGMP levels in most of the CNS were much lower, 33 to 69 nmoles per kg, wet weight, except in cerebellum, where the concentration of cGMP was 630 nmoles per kg, wet weight, 10 to 20 times that in any other region. Ischemia produced a 4-fold increase in cerebral cortical and cerebellar cAMP levels within 60 s, but with continued ischemia cAMP levels subsequently decreased. Levels of cGMP did not change during the initial 60 s of ischemia, and then decreased 60% in cerebral cortex and 80% in cerebellum. During the 1st week after birth, no changes in the levels of the two cyclic nucleotides in either forebrain or hindbrain were observed. Between 7 days and 21 days after birth, cAMP levels in forebrain, brain stem, and cerebellum increased 2-fold. The changes in cGMP levels between 7 days and adulthood were quite unlike those of cAMP. There was no change in forebrain cGMP, brain stem cGMP increased 2-fold, and in cerebellum cGMP rose dramatically, to a level 13 times that at 7 days.
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. (1997)

We have assessed the technical performance and robustness of NycoCard CRP Whole Blood, a near-patient test for C-reactive protein (CRP), when used in realistic daily routine situations in general practice clinics (GPC). Thirteen GPCs participated, five of them with technician staff. From 898 patients, split-sample measurements for CRP were made. Results from GPCs were compared with results from a turbidimetric laboratory method, traceable to international reference preparations (IFCC CRM 470). Results were evaluated in difference plots where the expected distribution, due to an estimated analytical variation, was compared with measured differences. Of all difference points, 91.5% (n = 819) were within a 95% prediction interval based on the imprecision of both methods. Mean bias (95% confidence interval) was -0.3 mg/L (-0.9 to 0.3). No differences in analytic quality were found between GPCs with technician staffs and GPCs without, and between test results obtained within the first and second week, compared with the rest of the study period. We find the test as good when used in GPCs as could be expected from laboratory testing, and consequently robust, which is a necessity for use in routine situations in general practice. General application of difference plots in test evaluations are discussed in detail.
A dynamic navigation scheme for vehicular ad hoc networks (2010)

In this paper, we present a dynamic navigation algorithm (DNA) that can be combined with GPS receivers, digital maps, and wireless technologies such as DSRC, 802.11p, and WiMAX. By calculating the score, a weighted sum of average vehicle speed, average inter-vehicle distance, road type, and road gain, for each candidate road, the DNA can generate a road score table and choose the road with the highest score among the candidate roads toward the destination. In addition, a dynamic rebroadcasting block (DRB) is designed in the DNA to carry out Road-Request (R-REQ) rebroadcasting function. The DRB mechanism can prevent from network congestion incurred by R-REQ rebroadcasting. For the purpose of performance evaluation, we compare our proposed DNA with three previous works via simulations. Simulation results have shown that the DNA performs much better than the other navigational schemes in reaching a destination with shorter travel distance and less travel time.
PSI (Ψ): a Private data Sharing Interface (2016)

We provide an overview of PSI ("a Private data Sharing Interface"), a system we are developing to enable researchers in the social sciences and other fields to share and explore privacy-sensitive datasets with the strong privacy protections of differential privacy.